Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers
{{output}}
BACKGROUND: Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an oncofetal protein present on many cancers. Zilovertamab vedotin (ZV) is an antibody–drug conjugate comprising a monoclonal antibody recognizing extracellular ROR1, a cleavable linker, an... ...
